NEW YORK, September 21, 2015 /PRNewswire/ --
ACI Association has initiated research coverage on the following
equities: American International Group, Inc. (NYSE: AIG),
Strategic Hotels & Resorts Inc. (NYSE: BEE),
Can-Fite Biopharma Ltd (NASDAQ: CANF), Pfizer, Inc.
(NYSE: PFE), and Merck & Company, Inc. (NASDAQ: MRK). On
Friday, September 18, 2015, NASDAQ
ended at 4,827.23 down 1.36%, DOW declined 1.74%, to finish the day
at 16,384.58, and the S&P closed at 1,958.03, down 1.62%.
Register for your complimentary reports at the links given below.
--
American International Group Inc.
--
American International Group Inc.'s stock edged lower by 1.11%
to close Friday's session at USD
57.78. The company's shares oscillated between USD 57.11 and USD 58.07 in trade during the day.
The stock recorded a trading volume of 18.15 million shares, which
was above its 50-day daily average volume of 8.17 million shares.
Over the last three days, American International Group Inc.'s
shares have declined by 1.48% and in the past one week the stock
has moved down 0.94%. Furthermore, over the last three months the
stock has lost 6.55% while in the past six months the shares have
picked up 3.29%. American International Group Inc. has a current
dividend yield of 1.94%. Further, the stock is trading at a price
to book ratio of 0.81. This compares to a historical PB ratio close
to 0.72. Sign up and read the free notes on AIG at:
http://www.aciassociation.com/AIG.pdf
--
Strategic Hotels & Resorts Inc.
--
The stock of Strategic Hotels & Resorts Inc. lost 0.64% to
close Friday's session at USD 13.91.
The shares of the company moved in the range of USD 13.91 and USD
14.00. A trading volume of 17.03 million shares was
recorded, which was greater than its 150-day daily average volume
of 3.40 million shares and above its 52-week average volume of 2.84
million shares. Over the last five days, Strategic Hotels &
Resorts Inc.'s shares have declined by 0.71%. Additionally, in the
past six months the shares have registered a profit of 7.41%. The
company has generated negative returns of 3.47% in the past one
month and positive returns of 8.59% in the last three months, on a
compounded total return basis. Further, the stock is trading at a
price to book ratio of 2.43 which compares to a historical PB ratio
close to 2.44. Register for free on ACI Association and access the
latest research on BEE at:
http://www.aciassociation.com/BEE.pdf
--
Can Fite Biopharma Ltd
--
Can Fite Biopharma Ltd's stock increased by 49.39% to close
Friday's session at USD 4.90. The
company's shares fluctuated in the range of USD 3.81 and USD
7.85 in trade during the day. A total of 40.70 million
shares exchanged hands, which surpassed its 50-day daily average
volume of 0.16 million shares and was above its 52-week average
volume of 0.50 million shares. Over the last three days Can Fite
Biopharma Ltd's shares have advanced 184.88% and in the past one
week the stock has moved up 188.24%. Furthermore, over the last
three months the stock has gained 84.06% and in the past six months
the shares have shed 22.31%. The company has returned 166.30% in
the past month and 36.87% in the last year, on a compounded total
return basis. The complete research on CANF is available for free
at: http://www.aciassociation.com/CANF.pdf
--
Pfizer Inc.
--
Pfizer Inc.'s stock slipped by 1.88% to close Friday's session
at USD 32.85. The company's shares
oscillated between USD 32.84 and USD
33.43. The stock recorded a trading volume of 36.75 million
shares, which was above its 50-day daily average volume of 24.79
million shares. Over the last five days, Pfizer Inc.'s shares have
declined by 0.36%. In addition, over the last three months the
stock has lost 3.89% while year to date the shares have picked up
8.15%. The company has given negative returns of 7.52% in the past
one month, whilst generating positive returns of 11.73% in the past
one year, on a compounded total return basis. Pfizer Inc. has a
current dividend yield of 3.41%. Additionally, the stock is trading
at a price to cash flow ratio of 14.42 and price to sales ratio of
4.20. Free in-depth research on PFE is available at:
http://www.aciassociation.com/PFE.pdf
--
Merck & Co Inc.
--
Merck & Co Inc.'s stock declined 3.39% to close Friday's
session at USD 52.13. The share price
vacillated between USD 51.91 and USD
53.87 in trade during the day. The stock recorded a trading
volume of 29.00 million shares, which was above its 50-day daily
average volume of 11.56 million shares. Over the last three days
Merck & Co Inc.'s shares have declined by 2.65% and in the past
one week the stock has moved up 0.08%. Moreover, in the last six
months the stock has lost 11.01% and year to date the shares have
shed 5.83%. Merck & Co Inc. has a current dividend yield of
3.45%. Further, the stock is trading at a price to book ratio of
3.17. This compares to a historical PB ratio close to 3.31.
Additionally, the stock is trading at a price to cash flow ratio of
24.38 and price to sales ratio of 3.65. The complimentary notes on
MRK can be downloaded in PDF format at:
http://www.aciassociation.com/MRK.pdf
--
About ACI Association:
Active Charter Investors Association ("ACI Association")
produces regular sponsored and non-sponsored reports, articles,
stock market blogs, and popular investment newsletters covering
equities listed on NYSE and NASDAQ and micro-cap stocks. ACI
Association has two distinct and independent departments. One
department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ACI Association has not been compensated; directly or
indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein.
NO WARRANTY
ACI Association, the Author, the Reviewer and the Sponsor
(collectively referred to as the "Publishers") are not responsible
for any error which may be occasioned at the time of printing of
this document or any error, mistake or shortcoming. No liability is
accepted by the Publishers whatsoever for any direct, indirect or
consequential loss arising from the use of this document. The
Publishers expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, the Publishers do not (1) guarantee the accuracy,
timeliness, completeness or correct sequencing of the information,
or (2) warrant any results from use of the information. The
included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ACI Association nor any party affiliated
with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our
report(s), read our disclosures, or for more information, visit
http://www.aciassociation.com/.
RESTRICTIONS
ACI Association is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.aciassociation.com